WallStreetZenWallStreetZen

NASDAQ: HBIO
Harvard Bioscience Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for HBIO

Based on 2 analysts offering 12 month price targets for Harvard Bioscience Inc

Min Forecast
$2.00+401.25%
Avg Forecast
$2.50+526.57%
Max Forecast
$3.00+651.88%

Should I buy or sell HBIO stock?

Based on 2 analysts offering ratings for Harvard Bioscience Inc.

Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their HBIO stock forecasts and price targets.

HBIO stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-09-10
lockedlocked$00.00+00.00%2025-05-13

1 of 1

Forecast return on equity

Is HBIO forecast to generate an efficient return?

Company
8.49%
Industry
15.43%
Market
-22.59%
HBIO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is HBIO forecast to generate an efficient return on assets?

Company
1.67%
Industry
11.03%
HBIO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

HBIO revenue growth forecast

How is HBIO forecast to perform vs Medical Instruments & Supplies companies and vs the US market?

Company
-1.63%
Industry
3.75%
Market
141.43%
HBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
HBIO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

HBIO vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
HBIO$0.40$2.50+526.57%Buy
CUPR$0.90N/AN/A
FEMY$0.58$7.00+1,111.07%Strong Buy
NXGL$2.61N/AN/A
EKSO$4.60$34.75+655.43%Strong Buy
View Top Medical Stocks

Harvard Bioscience Stock Forecast FAQ

Is Harvard Bioscience Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: HBIO) stock is to Buy HBIO stock.

Out of 2 analysts, 0 (0%) are recommending HBIO as a Strong Buy, 2 (100%) are recommending HBIO as a Buy, 0 (0%) are recommending HBIO as a Hold, 0 (0%) are recommending HBIO as a Sell, and 0 (0%) are recommending HBIO as a Strong Sell.

If you're new to stock investing, here's how to buy Harvard Bioscience stock.

What is HBIO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: HBIO) forecast ROE is 8.49%, which is considered weak.

What is HBIO's Price Target?

According to 2 Wall Street analysts that have issued a 1 year HBIO price target, the average HBIO price target is $2.50, with the highest HBIO stock price forecast at $3.00 and the lowest HBIO stock price forecast at $2.00.

On average, Wall Street analysts predict that Harvard Bioscience's share price could reach $2.50 by Sep 10, 2026. The average Harvard Bioscience stock price prediction forecasts a potential upside of 526.57% from the current HBIO share price of $0.40.

What is HBIO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: HBIO) forecast ROA is 1.67%, which is lower than the forecast US Medical Instruments & Supplies industry average of 11.03%.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.